Australia fines Roche for marketing violations

Roche was fined $400,000 for violations of Medicines Australia's code of conduct, including an offer to fund a nurse's salary if a clinic increased use of Pegasys, its hepatitis C drug. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.